Renal manifestations in a cohort of pediatric patients with inflammatory bowel disease

Afroditi Kourti1, Chrysoula Kosmeri1, Aikaterini Chira1

  • 1Department of Paediatric Gastroenterology, Hepatology and Nutrition, 3(rd) Department of Paediatrics, Attikon University General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Insights

Renal manifestations occur in 16% of pediatric inflammatory bowel disease (IBD) patients, including glomerulonephritis and IBD-related kidney damage. Early detection is crucial for managing these uncommon IBD complications.

Area of Science:

  • Pediatric Nephrology
  • Gastroenterology
  • Inflammatory Bowel Disease (IBD)

Background:

  • Renal involvement is an uncommon complication of pediatric inflammatory bowel disease (IBD).
  • Early identification and management of renal manifestations in IBD are essential.

Purpose of the Study:

  • To characterize the spectrum of renal involvement in pediatric patients with IBD.
  • To reduce diagnostic delays and improve management of renal complications in pediatric IBD.

Main Methods:

  • Retrospective analysis of renal function in pediatric IBD patients (<18 years).
  • Data collected from January 2019 to January 2023.
  • Inclusion of urinalysis and further investigations for abnormal findings.

Main Results:

  • 16% of 75 pediatric IBD patients exhibited renal manifestations.
  • Urinalysis abnormalities included proteinuria, hematuria, and glycosuria.
  • Diagnoses comprised glomerulonephritis, medication-induced renal damage, pyelonephritis with tubulointerstitial nephritis, thin basement membrane disease, IBD-related renal involvement, and amyloidosis-induced chronic renal failure.

Conclusions:

  • Clinicians must recognize the potential for renal manifestations in pediatric IBD.
  • Awareness facilitates early diagnosis and prevention of renal complications.
  • Prompt management can mitigate long-term renal damage in IBD patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
210
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
438
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
124
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156